
معرفی
Agneta Simionescu is Professor and Graduate Coordinator in Clemson University's College of Engineering, Computing and Applied Sciences, leading research in cardiovascular tissue engineering with focus on diabetes-resistant biomaterials. Her work develops tissue-engineered blood vessels, mitral valves, and cardiac muscle to combat diabetic deterioration through regenerative medicine approaches.
Education
- Ph.D. in Biochemistry/Cell Biology, Romanian Academy of Science, Bucharest (2001)
Research Focus
Her lab investigates diabetes-related biomaterial modifications including irreversible collagen-elastin scaffold alterations and cardiovascular stiffness changes. Key approaches involve antioxidant-treated diabetes-resistant scaffolds, diabetic stem cell characterization (differentiation and mechanoresponses), and microvascular network formation through proangiogenic peptide immobilization. Current efforts optimize biomaterial stiffness and validate therapies in diabetic animal models.
Publication Trends
Recent work (2020-2023) emphasizes bioreactor development for dynamic conditioning, molecular mechanisms of diabetic aortic valve disease, and pentagalloyl glucose stabilization of vascular tissues. Key themes include stem cell-based valve preservation, acellular scaffold characterization, and diabetes-resistant vascular graft engineering using polyphenol treatments.
Awards
No scientific awards specified in source materials.
Advising & Grants
As Graduate Coordinator, she oversees bioengineering programs. Collaborations with CUBEInC (Clemson University Biomedical Engineering Innovation Consortium) indicate active grant-funded research in cardiovascular tissue engineering, though specific grants aren't detailed.
Laboratory
The Tissue Engineering Lab develops regenerative solutions for diabetic cardiovascular disease, focusing on blood vessels, mitral valves, and cardiac muscle. Current projects include diabetes-resistant scaffold development, stem cell therapies, and biomaterial-stiffness optimization, with translational work involving surgeons through CUBEInC partnerships.




